Excited to present REGENT-1 study data at #ADA2025 this week in Chicago!
New findings highlight the potential of our pulsed electric field (PEF) system to impact:
✅ Insulin sensitivity
✅ Beta cell function
✅ Dose responsivity
#Type2Diabetes #Endogenex #ReCETStudy
159
Groundbreaking data at #DDW2025:
AI-driven 3D spatial analysis reveals profound immune dysregulation and structural remodeling in T2D duodenums.
Presented by @babudayyeh, the first-of-its-kind abstract marks a major advance in understanding diabetic duodenopathy.
#T2D #duodenum
Endogenex retweeted
Mayo Clinic researchers are seeking volunteers ages 22-70 with a BMI between 27-40 for a randomized study of a device used for the treatment of type 2 diabetes. Contact [email protected] or visit mayocl.in/40Tvhul for information.
Endogenex is adding to its leadership team. We are excited to announce Krissy Wright as the new Chief Financial Officer.
prnewswire.com/news-releases…
#diabetes #GItwitter
1
123
Exciting News! Endogenex announces enrollment of the first patient in the ReCET Clinical Study.
Led by Dr. Andre Teixeira at Orlando Health, this milestone marks a significant step in our mission to transform diabetes care. Read more in our press release below. 👇
1
180
Endogenex retweeted
A new paradigm suggesting that the integrative function of the duodenum in orchestrating the metabolic response is altered in metabolic diseases due to inflammation. This could represent a novel, potentially disease-modifying therapeutic target for type II diabetes. #diabetes2 #duodenum
Have you heard of diabetic duodenopathy? This refers to endoscopic and histological changes in the duodenum as a metabolic adaptation to diabetes. Look out for it! Courtesy of @babudayyeh @ESGE_news
Endogenex retweeted
Replying to @babudayyeh
@babudayyeh presenting cutting-edge data on endoscopic therapy approaches to #diabetes management
A glimpse into the future!
@DDWMeeting #DDW2024
Knowing the risk for Type 2 Diabetes & being diagnosed is half the battle.
Today is World Diabetes Day. One in ten adults worldwide have diabetes, yet close to half are undiagnosed.
#Endogenex supports awareness, prevention, & improved treatment options for people with #T2D
November is Diabetes Awareness Month-time to bring to light the challenges faced by people worldwide living with #diabetes. From prevention to the search for alternative treatment options, the #endogenex team supports improved outcomes & quality of life for those living with #T2D
121
EMINENT Clinical Study data being presented today at The European Association for the Study of Diabetes #EASD2023. @CelineBusch, MD et al. oral abstract highlights 12-month results in patients treated with the ReCET™ System
cattendee.abstractsonline.co…
#type2diabetes #GITwitter
ReCET Procedure in people with T2D was highlighted at the #ADA2023 . Data from REGENT-1 & EMINENT clinical studies outline early safety & feasibility experience. Thank you to Investigators from Australia, The Netherlands, & USA for your work in these studies.
119
Next up #ADA2023 from June 23 - 26 in San Diego. #type2diabetes #ReCET #diabetesmanagement #gastroenterology
122
Endogenex retweeted
Geoff Pardo and Stacey Pugh talk about Stacey’s career that began at the bedside as a trauma nurse and is now leading the charge at @Endogenex to take a new approach to Type 2 Diabetes treatment. Listen to the conversation: medtechmvp.com/media/medtech…
@endogenex CEO, Stacey Pugh, shares her career experience in Med Tech, vision for Endogenex, and its mission for improving outcomes in people with Type 2 Diabetes.
medtechmvp.com/media/medtech…
1
38
Endogenex retweeted
#Endogenex, developer of a procedure for treating type 2 #diabetes, announced today that it appointed Stacey Pugh as its new CEO.
More from @endogenex, HERE: drugdeliverybusiness.com/end…
#Surgical #Finance
It’s Alert! Day, a reminder to evaluate your risk factors for Type 2 Diabetes.
Take the ADA risk test diabetes.org/diabetes/risk-t…
endogenex.com
#type2diabetes #diabetesawareness #Endogenex
110



















